Welcome to Thrombosis Adviser

A Venous & Arterial Thrombosis Resource
For

Adviser’s Picks

  • VTE Treatment in Challenging Patient Populations
    Read more
  • Dosing Schemas of the NOACs for VTE Treatment
    Read more
  • Are NOACs Associated with Better Renal Outcomes than VKAs in Patients with NVAF?
    Read more
  • ESC Heart and Stroke Conference Highlights
    Read more
  • Improving AF Detection: The Evolving Role of Technology in Stroke Prevention
    Read more
  • LINC 2019 Highlights
    Read more
  • Interpreting Safety Results of NOACs Based on Bleeding Risk
    Read more
  • Managing the multi-morbid patient with AF: Focus on patients with renal impairment
    Read more
  • Professor Craig I. Coleman about challenges in interpreting real-world studies involving the NOACs
    Read more
  • Residual MACE in CAD: What Are the Long-Term Adverse Cardiac Events to Worry About?
    Read more

Never miss out on the latest news!

Over 4,000 healthcare professionals have already signed up.

Subscribe
When to use a reduced NOAC dose 02:12 min
Join the Conversation

Join the Conversation

Thrombosis Connection, A Healthcare Professionals’ Forum welcomes individuals interested in sharing, developing and fostering innovative solutions in the field of thrombosis.

Join LinkedIn Group